Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101983-101983
Open Access | Times Cited: 20

Showing 20 citing articles:

Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies
Eleftheria Kampouri, Jessica S Little, Kai Rejeski, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Open Access | Times Cited: 52
Vaccination of Adults With Cancer: ASCO Guideline
Mini Kamboj, Kari Bohlke, Deana M. Baptiste, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1699-1721
Closed Access | Times Cited: 25
Vaccine schedule recommendations and updates for patients with hematologic malignancy post‐hematopoietic cell transplant or CAR T‐cell therapy
Gemma Reynolds, Victoria Hall, Benjamin W. Teh
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Open Access | Times Cited: 26
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study
Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 2, pp. 542-554
Closed Access | Times Cited: 8
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy
María Stefania Infante, David Nemirovsky, Sean M. Devlin, et al.
Transplantation and Cellular Therapy (2023) Vol. 30, Iss. 1, pp. 116.e1-116.e12
Open Access | Times Cited: 14
Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant
Jennifer VanOudenhove, Yuxin Liu, Raman Nelakanti, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320744-e0320744
Open Access
COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy
Eleftheria Kampouri, Joshua A. Hill, M. Veronica Dioverti
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Closed Access | Times Cited: 10
Managing Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy
Nausheen Ahmed, Olalekan O. Oluwole, Zahra Mahmoudjafari, et al.
Clinical Hematology International (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 3
Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis
Leyla Sharifi Aliabadi, Mojtaba Azari, Mohammad Reza Taherian, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Ankit Mittal, Javier T Solera, Victor H. Ferreira, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 11, pp. 706.e1-706.e7
Open Access | Times Cited: 7
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)
Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis
Alexander Nikoloudis, Ines Julia Neumann, Veronika Buxhofer‐Ausch, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1534-1534
Open Access | Times Cited: 4
Comparable CD8+ T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals
Eva Tranter, Marco Frentsch, Marie Luise Hütter‐Krönke, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Open Access | Times Cited: 1
COVID‐19 outcomes in haemopoietic stem cell transplant recipients in Western Australia: the value of vaccination and antiviral therapy
Jacques A. J. Malherbe, Peter Boan, Duncan Purtill, et al.
Internal Medicine Journal (2024) Vol. 54, Iss. 4, pp. 664-670
Open Access | Times Cited: 1
Oncology: What You May Have Missed in 2023
Courtney H. Coschi, Lorin Dodbiba, DuPont Guerry
Annals of Internal Medicine (2024) Vol. 177, Iss. 5_Supplement, pp. S57-S70
Closed Access | Times Cited: 1
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients—A Tailored Approach Based on SARS-CoV-2 Vaccine Response
Krischan Braitsch, Samuel Jeske, Jacob Stroh, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 871-871
Open Access | Times Cited: 1
Targeting enhanced neutralizing antibody responses via increased germinal center activity: early-phase vaccine trials with novel clinical designs
William O. Hahn, Joshua A. Hill, James G. Kublin
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 6, pp. 323-330
Closed Access | Times Cited: 2
Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination
Ksenia V. Zornikova, Nataliia O Ivanova, O. A. Aleshina, et al.
Russian journal of hematology and transfusiology (2024) Vol. 69, Iss. 2, pp. 200-216
Open Access
First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations from a Canadian Consensus Guideline Consortium
Sahar Khan, Debra Bergstrom, Julie Anne Côté, et al.
Clinical Lymphoma Myeloma & Leukemia (2024)
Open Access
Pulmonary Immunocompromise in Stem Cell Transplantation and Cellular Therapy
Mahnoor Mir, Saadia A. Faiz, Anuradha G Bommakanti, et al.
Clinics in Chest Medicine (2024) Vol. 46, Iss. 1, pp. 129-147
Closed Access
Vaccinations in children with hematologic malignancies and those receiving hematopoietic stem cell transplants or cellular therapies
Kari Neemann, Alice I. Sato
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Open Access | Times Cited: 1
Page 1

Scroll to top